239 related articles for article (PubMed ID: 28007765)
21. A unique Oct4 interface is crucial for reprogramming to pluripotency.
Esch D; Vahokoski J; Groves MR; Pogenberg V; Cojocaru V; Vom Bruch H; Han D; Drexler HC; Araúzo-Bravo MJ; Ng CK; Jauch R; Wilmanns M; Schöler HR
Nat Cell Biol; 2013 Mar; 15(3):295-301. PubMed ID: 23376973
[TBL] [Abstract][Full Text] [Related]
22. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells.
Heng JC; Feng B; Han J; Jiang J; Kraus P; Ng JH; Orlov YL; Huss M; Yang L; Lufkin T; Lim B; Ng HH
Cell Stem Cell; 2010 Feb; 6(2):167-74. PubMed ID: 20096661
[TBL] [Abstract][Full Text] [Related]
23. GATA family members as inducers for cellular reprogramming to pluripotency.
Shu J; Zhang K; Zhang M; Yao A; Shao S; Du F; Yang C; Chen W; Wu C; Yang W; Sun Y; Deng H
Cell Res; 2015 Feb; 25(2):169-80. PubMed ID: 25591928
[TBL] [Abstract][Full Text] [Related]
24. Fusion of Reprogramming Factors Alters the Trajectory of Somatic Lineage Conversion.
Velychko S; Kang K; Kim SM; Kwak TH; Kim KP; Park C; Hong K; Chung C; Hyun JK; MacCarthy CM; Wu G; Schöler HR; Han DW
Cell Rep; 2019 Apr; 27(1):30-39.e4. PubMed ID: 30943410
[TBL] [Abstract][Full Text] [Related]
25. Enhanced OCT4 transcriptional activity substitutes for exogenous SOX2 in cellular reprogramming.
Marthaler AG; Adachi K; Tiemann U; Wu G; Sabour D; Velychko S; Kleiter I; Schöler HR; Tapia N
Sci Rep; 2016 Jan; 6():19415. PubMed ID: 26762895
[TBL] [Abstract][Full Text] [Related]
26. CRISPR-Based Chromatin Remodeling of the Endogenous Oct4 or Sox2 Locus Enables Reprogramming to Pluripotency.
Liu P; Chen M; Liu Y; Qi LS; Ding S
Cell Stem Cell; 2018 Feb; 22(2):252-261.e4. PubMed ID: 29358044
[TBL] [Abstract][Full Text] [Related]
27. Key features of the POU transcription factor Oct4 from an evolutionary perspective.
Bakhmet EI; Tomilin AN
Cell Mol Life Sci; 2021 Dec; 78(23):7339-7353. PubMed ID: 34698883
[TBL] [Abstract][Full Text] [Related]
28. A role for mitotic bookmarking of SOX2 in pluripotency and differentiation.
Deluz C; Friman ET; Strebinger D; Benke A; Raccaud M; Callegari A; Leleu M; Manley S; Suter DM
Genes Dev; 2016 Nov; 30(22):2538-2550. PubMed ID: 27920086
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the determinants for improved pluripotency induction and maintenance by engineered SOX17.
Hu H; Ho DHH; Tan DS; MacCarthy CM; Yu CH; Weng M; Schöler HR; Jauch R
Nucleic Acids Res; 2023 Sep; 51(17):8934-8956. PubMed ID: 37607832
[TBL] [Abstract][Full Text] [Related]
30. Inducing goat pluripotent stem cells with four transcription factor mRNAs that activate endogenous promoters.
Chen H; Zuo Q; Wang Y; Song J; Yang H; Zhang Y; Li B
BMC Biotechnol; 2017 Feb; 17(1):11. PubMed ID: 28193206
[TBL] [Abstract][Full Text] [Related]
31. Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming.
Gao Y; Chen J; Li K; Wu T; Huang B; Liu W; Kou X; Zhang Y; Huang H; Jiang Y; Yao C; Liu X; Lu Z; Xu Z; Kang L; Chen J; Wang H; Cai T; Gao S
Cell Stem Cell; 2013 Apr; 12(4):453-69. PubMed ID: 23499384
[TBL] [Abstract][Full Text] [Related]
32. Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs.
Velychko S; Adachi K; Kim KP; Hou Y; MacCarthy CM; Wu G; Schöler HR
Cell Stem Cell; 2019 Dec; 25(6):737-753.e4. PubMed ID: 31708402
[TBL] [Abstract][Full Text] [Related]
33. Esrrb Unlocks Silenced Enhancers for Reprogramming to Naive Pluripotency.
Adachi K; Kopp W; Wu G; Heising S; Greber B; Stehling M; Araúzo-Bravo MJ; Boerno ST; Timmermann B; Vingron M; Schöler HR
Cell Stem Cell; 2018 Aug; 23(2):266-275.e6. PubMed ID: 29910149
[TBL] [Abstract][Full Text] [Related]
34. Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.
Bazley FA; Liu CF; Yuan X; Hao H; All AH; De Los Angeles A; Zambidis ET; Gearhart JD; Kerr CL
Stem Cells Dev; 2015 Nov; 24(22):2634-48. PubMed ID: 26154167
[TBL] [Abstract][Full Text] [Related]
35. Nac1 facilitates pluripotency gene activation for establishing somatic cell reprogramming.
Choi H; Park HJ; Kim H; Kim J; Lee YK; Kim J
Biochem Biophys Res Commun; 2019 Oct; 518(2):253-258. PubMed ID: 31412978
[TBL] [Abstract][Full Text] [Related]
36. The J domain of papovaviral large tumor antigen is required for synergistic interaction with the POU-domain protein Tst-1/Oct6/SCIP.
Sock E; Enderich J; Wegner M
Mol Cell Biol; 1999 Apr; 19(4):2455-64. PubMed ID: 10082511
[TBL] [Abstract][Full Text] [Related]
37. Pluripotent state induction in mouse embryonic fibroblast using mRNAs of reprogramming factors.
El-Sayed AK; Zhang Z; Zhang L; Liu Z; Abbott LC; Zhang Y; Li B
Int J Mol Sci; 2014 Nov; 15(12):21840-64. PubMed ID: 25437916
[TBL] [Abstract][Full Text] [Related]
38. Identification of the nuclear localization signal of the POU domain protein Tst-1/Oct6.
Sock E; Enderich J; Rosenfeld MG; Wegner M
J Biol Chem; 1996 Jul; 271(29):17512-8. PubMed ID: 8663425
[TBL] [Abstract][Full Text] [Related]
39. Ash2l interacts with Oct4-stemness circuitry to promote super-enhancer-driven pluripotency network.
Tsai PH; Chien Y; Wang ML; Hsu CH; Laurent B; Chou SJ; Chang WC; Chien CS; Li HY; Lee HC; Huo TI; Hung JH; Chen CH; Chiou SH
Nucleic Acids Res; 2019 Nov; 47(19):10115-10133. PubMed ID: 31555818
[TBL] [Abstract][Full Text] [Related]
40. Directed Evolution of Reprogramming Factors by Cell Selection and Sequencing.
Veerapandian V; Ackermann JO; Srivastava Y; Malik V; Weng M; Yang X; Jauch R
Stem Cell Reports; 2018 Aug; 11(2):593-606. PubMed ID: 30078555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
